Genome Mining of the Marine Actinomycete Sp. DUT11 and Discovery of Tunicamycins As Anti-complement Agents
Overview
Affiliations
Marine actinobacteria are potential producers of various secondary metabolites with diverse bioactivities. Among various bioactive compounds, anti-complement agents have received great interest for drug discovery to treat numerous diseases caused by inappropriate activation of the human complement system. However, marine streptomycetes producing anti-complement agents are still poorly explored. In this study, a marine-derived strain sp. DUT11 showing superior anti-complement activity was focused, and its genome sequence was analyzed. Gene clusters showing high similarities to that of tunicamycin and nonactin were identified, and their corresponding metabolites were also detected. Subsequently, tunicamycin I, V, and VII were isolated from sp. DUT11. Anti-complement assay showed that tunicamycin I, V, VII inhibited complement activation through the classic pathway, whereas no anti-complement activity of nonactin was detected. This is the first time that tunicamycins are reported to have such activity. In addition, genome analysis indicates that sp. DUT11 has the potential to produce novel lassopeptides and lantibiotics. These results suggest that marine are rich sources of anti-complement agents for drug discovery.
Thapa G, Han S, Paudel P, Kim M, Hong Y, Oh T J Microbiol Biotechnol. 2024; 34(9):1836-1847.
PMID: 39187447 PMC: 11485624. DOI: 10.4014/jmb.2404.04030.
Widada J, Damayanti E, Mustofa M, Dinoto A, Febriansah R, Hertiani T Microorganisms. 2023; 11(8).
PMID: 37630491 PMC: 10458361. DOI: 10.3390/microorganisms11081930.
Targeted Discovery of Cryptic Metabolites with Antiproliferative Activity.
Han E, Lee S, Hoshino S, Seyedsayamdost M ACS Chem Biol. 2022; 17(11):3121-3130.
PMID: 36228140 PMC: 10171914. DOI: 10.1021/acschembio.2c00588.
Complete Genome Sequence of the Marine-Derived Bacterium sp. Strain GMY02.
Widada J, Damayanti E, Mustofa Microbiol Resour Announc. 2021; 10(40):e0068121.
PMID: 34617791 PMC: 8496364. DOI: 10.1128/MRA.00681-21.
Goel N, Fatima S, Kumar S, Sinha R, Khare S Biotechnol Rep (Amst). 2021; 30:e00613.
PMID: 33996521 PMC: 8105627. DOI: 10.1016/j.btre.2021.e00613.